{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:36:41Z","timestamp":1754163401694,"version":"3.41.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02578-5","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:14:23Z","timestamp":1744359263000},"page":"1649-1657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of loco-regional treatments in neuroendocrine liver metastases compared to an hepato-cellular carcinoma cohort: a single-center study"],"prefix":"10.1007","volume":"48","author":[{"given":"B.","family":"Masoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4208-4372","authenticated-orcid":false,"given":"R. E.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"De Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bertazzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ceriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Colapietro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Pedicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ferrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G. A.","family":"Lania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zerbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Repici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Aghemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"18","key":"2578_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC et al (2008) One hundred years after \u2018carcinoid\u2019: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the united States. J Clin Oncol 26(18):3063\u20133072. https:\/\/doi.org\/10.1200\/JCO.2007.15.4377","journal-title":"J Clin Oncol"},{"key":"2578_CR2","doi-asserted-by":"publisher","unstructured":"O\u2019CONNOR JM et al (2014) Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: results from the large database of a multidisciplinary group clinical multicenter study. Mol Clin Oncol. https:\/\/doi.org\/10.3892\/MCO.2014.332","DOI":"10.3892\/MCO.2014.332"},{"key":"2578_CR3","doi-asserted-by":"publisher","unstructured":"Dasari A et al (2017) Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States, JAMA Oncol, 3(10):1335\u20131342,https:\/\/doi.org\/10.1001\/JAMAONCOL.2017.0589","DOI":"10.1001\/JAMAONCOL.2017.0589"},{"key":"2578_CR4","doi-asserted-by":"publisher","unstructured":"Pavel M et al (2012) ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary, Neuroendocrinology, 95(2):157\u2013176. https:\/\/doi.org\/10.1159\/000335597","DOI":"10.1159\/000335597"},{"key":"2578_CR5","doi-asserted-by":"publisher","unstructured":"Pavel M et al (2016) ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. https:\/\/doi.org\/10.1159\/000443167","DOI":"10.1159\/000443167"},{"key":"2578_CR6","doi-asserted-by":"publisher","unstructured":"Fazio N, La Salvia A (2023) Precision medicine in gastroenteropancreatic neuroendocrine neoplasms: where are we in 2023? Best Pract Res Clin Endocrinol Metab. https:\/\/doi.org\/10.1016\/J.BEEM.2023.101794","DOI":"10.1016\/J.BEEM.2023.101794"},{"key":"2578_CR7","doi-asserted-by":"publisher","unstructured":"Reig M et al (2022) BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update, J Hepatol, 76(3):681\u2013693. https:\/\/doi.org\/10.1016\/J.JHEP.2021.11.018","DOI":"10.1016\/J.JHEP.2021.11.018"},{"key":"2578_CR8","doi-asserted-by":"publisher","unstructured":"Lawson A et al (2023) Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis, Cancers (Basel), 15(12). https:\/\/doi.org\/10.3390\/CANCERS15123166","DOI":"10.3390\/CANCERS15123166"},{"key":"2578_CR9","doi-asserted-by":"publisher","unstructured":"de Franchis R et al (2022) Baveno VII\u2013 Renewing consensus in portal hypertension. J Hepatol. https:\/\/doi.org\/10.1016\/J.JHEP.2021.12.022","DOI":"10.1016\/J.JHEP.2021.12.022"},{"key":"2578_CR10","doi-asserted-by":"publisher","unstructured":"Nagtegaal ID et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology. https:\/\/doi.org\/10.1111\/HIS.13975","DOI":"10.1111\/HIS.13975"},{"key":"2578_CR11","doi-asserted-by":"publisher","unstructured":"Gaba RC et al (2017) Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy. J Vasc Interv Radiol 28(9):1210\u20131223.e3 https:\/\/doi.org\/10.1016\/J.JVIR.2017.04.025.","DOI":"10.1016\/J.JVIR.2017.04.025"},{"key":"2578_CR12","doi-asserted-by":"publisher","unstructured":"Gaba RC et al (2016) Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol. https:\/\/doi.org\/10.1016\/J.JVIR.2015.12.752","DOI":"10.1016\/J.JVIR.2015.12.752"},{"key":"2578_CR13","doi-asserted-by":"publisher","unstructured":"Tognolini A, Louie JD, Hwang GL, Hofmann LV, Sze DY, Kothary N (2010) Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization, J Vasc Interv Radiol, 21(3):339\u2013347. https:\/\/doi.org\/10.1016\/J.JVIR.2009.11.007","DOI":"10.1016\/J.JVIR.2009.11.007"},{"key":"2578_CR14","doi-asserted-by":"publisher","unstructured":"Khalilzadeh O et al (2017) Proposal of a new adverse event classification by the society of interventional radiology standards of practice committee. J Vasc Interv Radiol. https:\/\/doi.org\/10.1016\/J.JVIR.2017.06.019","DOI":"10.1016\/J.JVIR.2017.06.019"},{"issue":"1","key":"2578_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/S-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52\u201360. https:\/\/doi.org\/10.1055\/S-0030-1247132","journal-title":"Semin Liver Dis"},{"key":"2578_CR16","doi-asserted-by":"publisher","unstructured":"Barat M et al (2020) The Role of Interventional Radiology for the Treatment of Hepatic Metastases from Neuroendocrine Tumor: An Updated Review, J Clin Med, 9(7):1\u201321. https:\/\/doi.org\/10.3390\/JCM9072302","DOI":"10.3390\/JCM9072302"},{"key":"2578_CR17","doi-asserted-by":"publisher","unstructured":"Riesco-Martinez MC, Modrego A, Espinosa-Olarte P, La Salvia A, Garcia-Carbonero R (2022) Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives, Curr Treat Options Oncol, 23(9):1320\u20131337. https:\/\/doi.org\/10.1007\/s11864-022-01008-5","DOI":"10.1007\/s11864-022-01008-5"},{"key":"2578_CR18","doi-asserted-by":"publisher","unstructured":"Gupta S et al (2005) Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival, Cancer, 104(8):1590\u20131602. https:\/\/doi.org\/10.1002\/CNCR.21389","DOI":"10.1002\/CNCR.21389"},{"key":"2578_CR19","doi-asserted-by":"crossref","unstructured":"Eriksson BK, Larsson EG, Skogseid BM, L\u00f6fberg AM, L\u00f6relius LE, Oberg KE (1998) Liver embolizations of patients with malignant neuroendocrine Gastrointestinal tumors. Cancer.","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.3.CO;2-5"},{"issue":"4","key":"2578_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0889-8588(05)70372-5","volume":"10","author":"C Emmanouilides","year":"1996","unstructured":"Emmanouilides C, Glaspy J (1996) Opportunistic infections in oncologic patients. Hematol Oncol Clin North Am 10(4):841\u2013860. https:\/\/doi.org\/10.1016\/S0889-8588(05)70372-5","journal-title":"Hematol Oncol Clin North Am"},{"key":"2578_CR21","doi-asserted-by":"publisher","unstructured":"De T, Ba\u00e8re et al (1996) Liver abscess formation after local treatment of liver tumors. Hepatology. https:\/\/doi.org\/10.1053\/jhep.1996.v23.pm0008675161","DOI":"10.1053\/jhep.1996.v23.pm0008675161"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02578-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02578-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02578-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T04:32:01Z","timestamp":1753936321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02578-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2578"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02578-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}